RN(NP) Info and Updates
We do our best to keep you up to date on new information as it is released. However, it is your responsibility to check this page often to make sure you are aware of important updates and changes to your practice.
- September 30, 2020 - Narcotic and Controlled Drug Prescriptions for Personal Care Home Residents - Effective October 1, 2020, verbal orders from physicians and RN(NP)s for narcotics and controlled drugs that fall under the Health Canada Controlled Drugs and Substances Act (CDSA) may be accepted by pharmacists for residents of a personal care home (PCH) only. This exemption does NOT apply to patients who are not a resident of a personal care home at the time the verbal order is given. This temporary exemption (initiated in April 2020) has once again been jointly approved by CPSM, CPhM and CRNM, remaining in effect during the COVID-19 pandemic and may not extend beyond September 30, 2021. Click here to read more
- September 4, 2020 - Nurse Practitioner Regulation Framework Implementation Plan Project Underway - The Nurse Practitioner Regulation Framework Implementation Plan Project (NPR-FIPP) is a multi-year initiative commissioned by the Canadian Council of Registered Nurse Regulators (CCRNR). The NPR-FIPP looks at implementing the six basic elements of a model for NP regulation in Canada, including entry-level NP education programs preparing RNs to meet NP entry-level competencies across the life span and diverse practice settings, and a new, single entry-level examination for all NPs across the country. It also includes developing a common set of standards and principles surrounding standards of practice, continuing competence, registration/renewal, and re-entry to practice. You can stay up to date on the NPR-FIPP at the CCRNR website.
June 24, 2020 - Prescribing and Dispensing of Drugs to Treat COVID-19: Oral Dexamethasone - Recently, the results of a clinical trial involving dexamethasone for the treatment of COVID-19 in severely ill patients have been announced in the media. While this clinical trial was limited to severely ill COVID-19 patients, the announcement of these results has garnered significant attention. As a result, prescribers may encounter patients in the community seeking dexamethasone for personal use, as many healthcare professionals encountered with hydroxychloroquine. The College is urging your continued diligence in supporting clients with evidence-informed care. Click here to read more.
- April 17, 2020 - Ensuring Safe Access to M3P Prescriptions for Patients During COVID-19 Outbreak - The College of Physicians and Surgeons of Manitoba (CPSM), College of Registered Nurses of Manitoba (CRNM) and the College of Pharmacists of Manitoba (CPhM) have received several inquiries regarding measures to ensure safe patient access to Manitoba Prescribing Practices Program (M3P) drugs during the COVID-19 outbreak. Several registrants have also voiced their concern about maintaining safe prescribing practices while implementing social distancing where possible. Inquiries have also been received from prescribers regarding the appropriateness of virtual and phone visits for patients who require a M3P prescription.
In response to these inquiries, the CPSM, CRNM and CPhM are providing the following guidance when it comes to drugs that usually require an M3P form:
- April 7, 2020 - Updated Guidance on Narcotic and Controlled Drug Prescriptions for Personal Care Home Residents - Effective immediately, verbal orders from physicians and RN(NP)s for narcotics and controlled drugs that fall under the Health Canada Controlled Drugs and Substances Act (CDSA) may be accepted by pharmacists for residents of a personal care home (PCH) only. This exemption does NOT apply to patients who are not a resident of a personal care home at the time the verbal order is given.This temporary exemption shall remain in effect during the COVID-19 pandemic and may not extend beyond September 30, 2020. Click here to learn more.
- April 2020 - RN(NP) certification of death legislation proclaimed.
For your review and reference, click here to watch Dr. Younes Death Certification workshop. Let CRNM know once you've completed this presentation the first time which is required before completing any certification of death. In addition, note that it is in the scope of practice for an RN(NP) to order an autopsy and write a letter of expected death. To review the legislation, see sections 17, 18 of The Fatality Inquiries Act and sections 1, 14 , 43 of The Vital Statistics Act. RN(GNP)s are not able to sign certification of deaths.
- March 26, 2020 - Prescribing and Dispensing of Drugs to Treat COVID-19 - In these unprecedented times, your continued diligence will support all clients to get evidence-informed care. The media and internet focused attention on the use of certain medications to treat COVID-19 despite the lack of evidence. Some Manitoba pharmacies are now faced with shortages of certain medications for patients with conditions such as lupus or rheumatoid arthritis. Click here to learn more.
- March 2020 - RN(NP) Opioid Prescribing to Treat Non-Cancer Pain Practice Direction distinguishes the expectations based on risks and benefits for varying client situations, in relation to prescribing opioids to treat non-cancer pain.
The title RN(NP) is protected under The Regulated Health Professions Act. Its use is restricted to RNs who have met and maintain the requirements for registration on the extended practice register. Click here to read more about the use of regulated professional titles or click here to view the webinar.
Changing Your Information
Complete this form to change your client population
All RN(NP)s are required to provide current employer contact information. To make changes, log in to your online profile using your registration number and password and click the “NP Contact Info” button in the top navigation bar.